Biogen (BIIB)
(Delayed Data from NSDQ)
$230.04 USD
-5.28 (-2.24%)
Updated May 16, 2024 04:00 PM ET
After-Market: $229.85 -0.19 (-0.08%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Brokerage Reports
Biogen Inc. [BIIB]
Reports for Purchase
Showing records 781 - 799 ( 799 total )
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Encouraging data on oral MS drug, BG-12, raises hopes of strong growth ahead....
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Moderate Outperform : Encouraging data on oral MS drug, BG-12, raises hopes of strong growth ahead....
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Disappointing sales performance by Tysabri & further competition expected from launch of Novartis
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Tysabris poor off take & disappointing momentum in weekly additions raises.
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Concern remains over likely implementation of price cuts in Europe in Q3 CY10 & lack of meaningful catalysts in 2010
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Biotech Balance Sheet
Provider: Merriman Curhan Ford & Co.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Performance of Tysabri holds key to overall growth in near term
Provider: FIRST GLOBAL
Analyst: THOMAS K
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Calendar Of Events.
Provider: WALL STREET ACCESS CORP.
Company: Biogen Inc.
Industry: Medical - Biomedical and Genetics
Life Sciences - Biotechnology - Biotech Balance Sheet
Provider: MERRIMAN CURHAN FORD & CO.